Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.
The third hypervariable region, or V3 loop, represents the principal neutralizing domain of the gp120 envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1). Sequential viral isolates from a laboratory worker (LW) accidentally infected with HIV-1IIIB in 1985 were analyzed using type-specific neutralizing monoclonal antibodies directed to the V3 loop. A single amino acid substitution, Ala-->Thr at position 21 in the V3 loop of HIV-1LW isolated in 1987, was shown to determine the loss of the neutralizing epitope recognized by one of the monoclonal antibodies (M77). However, this antibody efficiently recognized linear V3 loop peptides containing either the Ala or Thr residue at position 21, indicating that a local change in conformation was responsible for the epitope loss in the native gp120. Molecular modeling studies, experimentally supported by different amino acid replacements at position 21, indicated that the Ala-->Thr substitution leads to a drastic change in the domain of the V3 loop, which contains the complementary surface for antibody binding. These results provide evidence for the first time that a conformation-dependent epitope within the V3 loop of HIV-1 is involved in the generation of neutralization escape mutants in vivo.
di Marzo Veronese
F
F
Department of Cell Biology, Advanced BioScience Laboratories, Inc., Kensington, Maryland 20895.
Reitz
M S
MS
Gupta
G
G
Robert-Guroff
M
M
Boyer-Thompson
C
C
Louie
A
A
Gallo
R C
RC
Lusso
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000382:microbiology* / Q000635:transmission; D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal; D002460:Cell Line; D000939:Epitopes / Q000737:chemistry / Q000235:genetics*; D014644:Genetic Variation; D015726:Giant Cells; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D015497:HIV-1 / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D017056:Medical Laboratory Personnel; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional; D009784:Occupational Diseases / Q000382:microbiology*; D017354:Point Mutation; D017433:Protein Structure, Secondary; D015183:Restriction Mapping
D000911:Antibodies, Monoclonal; D000939:Epitopes; D015699:HIV Envelope Protein gp120